Hemofiltration in Sepsis and Septic Shock

  • P. Rogiers
  • H. Zhang
  • J.-L. Vincent
Conference paper
Part of the Yearbook of Intensive Care and Emergency Medicine book series (YEARBOOK, volume 1997)


Sepsis and septic shock are leading causes of morbidity and mortality in the intensive care setting. The mortality rate in patients with septic shock ranges from 40 to 80%. The primary therapeutic strategy for septic shock involves, on the one hand, hemodynamic stabilization including restoration of blood pressure, and optimization of oxygen delivery [1, 2], and on the other hand, administration of antibiotics together with removal of the septic source whenever indicated. Several clinical studies have demonstrated a close relationship between the severity of sepsis, mortality rate, and the release of cytokines including tumor necrosis factor (TNF), and interleukins (IL)-1, IL-6, and IL-8 [3–6]. The release of various mediators can be involved in reduction in myocardial contractility, increase in oxygen demand, and alteration in oxygen extraction capabilities during septic shock [7]. Modulation of the immune response is therefore considered as another important therapeutic intervention. A number of clinical trials investigating the effects of anti-endotoxin, or anti-cytokine interventions did not consistently show an improvement in survival in patients with sepsis or septic shock [8, 9]. Importantly, various factors such as inclusion criteria, dose, and timing could influence the results. Moreover, a single immunotherapy may not be sufficient to blunt the inflammatory and immunological process, so that a combination of therapies may be necessary to improve outcome from septic shock.


Septic Shock Acute Renal Failure Mean Arterial Pressure Endotoxic Shock Arachidonic Acid Metabolite 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Shoemaker WC (1987) Circulatory mechanisms of shock and their mediators. Crit Care Med 15: 787–794PubMedCrossRefGoogle Scholar
  2. 2.
    Edwards JD, Brown GCS, Nightingale P, et al (1989) The use of survivors’ cardiorespiratory values as therapeutic goals in septic shock. Crit Care Med 17: 1098–1103PubMedCrossRefGoogle Scholar
  3. 3.
    Parrillo JE (1993) Pathogenetic mechanisms of septic shock. N Engl J Med 328: 1471–1477PubMedCrossRefGoogle Scholar
  4. 4.
    Damas P, Reuter A, Gysen P, et al (1989) Tumor necrosis factor and interleukin-1 serum levels during severe sepsis in humans. Crit Care Med 17: 975–979PubMedCrossRefGoogle Scholar
  5. 5.
    Calandra T, Baumgartner JD, Grau DG, et al (1990) Prognostic values of tumor necrosis factor/cachectin, interleukin-1, interferon-alpha, and interferon-gamma in the serum of patients with septic shock. J Infect Dis 161: 982–987PubMedCrossRefGoogle Scholar
  6. 6.
    Pinsky MR, Vincent JL, Kahn RJ, et al (1990) Inflammatory mediators of septic shock in man. Am Rev Respir Dis 141: A512 (Abst)Google Scholar
  7. 7.
    Vincent JL (1991) Diagnostic and medical management/supportive care of patients with Gram-negative bacteremia and septic shock. Infect Dis Clin North Am 5: 807–816PubMedGoogle Scholar
  8. 8.
    Hoffman WD, Natanson C (1993) The role of endotoxin in bacterial septic shock. In: Vincent JL (ed) Yearbook of Intensive Care and emergency medicine 1993. Springer, Berlin Heidelberg New York, pp 49–63Google Scholar
  9. 9.
    Fisher C (1992) Clinical trials of immunotherapy for sepsis. Crit Care Med 20: 721–723CrossRefGoogle Scholar
  10. 10.
    Gomez A, Wang R. Unruh H, et al (1990) Hemofiltration reverses left ventricular dysfunction during sepsis in dogs. Anesthesiology 73: 671–685PubMedCrossRefGoogle Scholar
  11. 11.
    Stein B, Pfenninger E, Grunert A, et al (1990) Influence of continuous hemofiltration on hemodynamics and central blood volume in experimental endotoxic shock. Intensive Care Med 16: 494–499PubMedCrossRefGoogle Scholar
  12. 12.
    Freeman BD, Yatsiv I, Natanson C, et al (1995) Continuous arteriovenous hemofiltration does not improve survival in a canine model of septic shock. J Am Coll Surg 180: 286–292PubMedGoogle Scholar
  13. 13.
    Lee PA, Matson JR, Pryor RW, et al (1993) Continuous arteriovenous hemofiltration therapy for Staphylococcus aureus-induced septicemia in immature swine. Crit Care Med 21: 914–924PubMedCrossRefGoogle Scholar
  14. 14.
    Mink SN, Jha P, Wang R, et al (1995) Effects of continuous arteriovenous hemofiltration with systemic vasopressor therapy on depressed left ventricular contractility and tissue oxygen delivery in canine Escherichia coli sepsis. Anesthesiology 83: 178–190PubMedCrossRefGoogle Scholar
  15. 15.
    Heidemann SM, Ofenstein JP, Sarnaik AP (1994) Efficacy of continuous arteriovenous hemofiltration in endotoxic shock. Circ Shock 44: 183–187PubMedGoogle Scholar
  16. 16.
    Grootendorst AF, van Bommel EFH, van der Hoven B, et al (1992) High-volume hemofiltration improves hemodynamics of endotoxin-induced shock in the pig. J Crit Care 7: 67–75CrossRefGoogle Scholar
  17. 17.
    Grootendorst AF, van Bommel EFH, van der Hoven B, et al (1992) High volume hemofiltration improves right ventricular function of endotoxin-induced shock in the pig. Intensive Care Med 18: 235–240PubMedCrossRefGoogle Scholar
  18. 18.
    Grootendorst AF, van Bommel EF, van Leengoed LA, et al (1994) High volume hemofiltration improves hemodynamics and survival of pigs exposed to gut ischemia and reperfusion. Shock 2: 72–78PubMedCrossRefGoogle Scholar
  19. 19.
    Rogiers P, Zhang H, Smail N, et al (1996) High-volume hemofiltration improves hemodynamics in experimental endotoxic shock. Intensive Care Med 22: S396 (Abst)Google Scholar
  20. 20.
    Grootendorst AF, van Bommel EFH, van der Hoven B, et al (1993) Infusion of ultrafiltrate from endotoxemic pigs depresses myocardial performance in normal pigs. J Crit Care 8: 161–169PubMedCrossRefGoogle Scholar
  21. 21.
    Wendon J, Smithies M, Sheppard M, et al (1989) Continuous high volume veno-venous hemofiltration in acute renal failure. Intensive Care Med 15: 358–363PubMedCrossRefGoogle Scholar
  22. 22.
    Mauritz W, Sporn P, Schindler I, et al (1986) Acute renal failure in abdominal infection. Comparison of haemodialysis and continuous arteriovenous hemofiltration. Anesth Intensivther Notfallmed 21: 212–217Google Scholar
  23. 23.
    van Bommel E, Bouvy ND, So KI, et al (1995) Acute dialytic support for critically ill: Intermittent hemodialysis versus continuous arteriovenous hemodiafiltration. Am J Nephrol 15: 192–200Google Scholar
  24. 24.
    Lingnau W, Javorsky F, Resch D, et al (1995) Continuous hemofiltration improves multiple organ failure and outcome. Crit Care Med 23: A106 (Abst)Google Scholar
  25. 25.
    Vincent JL, Tielemans C (1995) Continuous hemofiltration in severe sepsis: Is it beneficial? J Crit Care 10: 27–32PubMedCrossRefGoogle Scholar
  26. 26.
    Goldfarb S, Golper TA (1994) Pro-inflammatory cytokines and hemofiltration membranes. J Am Soc Nephrol 5: 228–232PubMedGoogle Scholar
  27. 27.
    Sato T, Orlowski JP, Zborowski M (1993) Experimental study of extracorporeal perfusion for septic shock. ASAIO J 39: M790 - M793PubMedCrossRefGoogle Scholar
  28. 28.
    Gotloib L, Barzilay E, Shustak A, et al (1986) Hemofiltration in septic ARDS. The artificial kidney as an artificial endocrine lung. Resuscitation 13: 123–132Google Scholar
  29. 29.
    Bellomo R (1995) Continuous hemofiltration as blood purification in sepsis. New Horizons 3: 732–737PubMedGoogle Scholar
  30. 30.
    Cheadle WG, Hanasawa K, Gallinaro RN, et al (1991) Endotoxin filtration and immune stimulation improve survival from gram-negative sepsis. Surgery 110: 785–792PubMedGoogle Scholar
  31. 31.
    Schiffl H, Lang SM, König A, et al (1994) Biocompatible membranes in acute renal failure: Prospective case-controlled study. Lancet 344: 570–572Google Scholar
  32. 32.
    Hakim RM, Wingard RL, Parker RA (1994) Effect of the dialysis membrane in the treatment of patients with acute renal failure. N Engl J Med 331: 1338–1342PubMedCrossRefGoogle Scholar
  33. 33.
    Gasche Y, Pascual M, Suter PM, et al (1996) Complement depletion during haemofiltration with polyacrilonitrile membranes. Nephrol Dial Transplant 11: 117–119PubMedCrossRefGoogle Scholar
  34. 34.
    Millar AB, Armstrong L, van der Linden (1993) Cytokine production and hemofiltration in children undergoing cardiopulmonary bypass. Ann Thorac Surg 56: 1499–1502PubMedCrossRefGoogle Scholar
  35. 35.
    van Bommel EFH, Hesse CJ, Jutte NHPM, et al (1995) Cytokine kinetics (TNF-a, IL-1ß, IL-6) during continuous hemofiltration: A laboratory and clinical study. In: Sieberth HG, Stummvoll HK, Kierdort H (eds) Continuous extracorporeal treatment in multiple organ dysfunction syndrome. Karger, Basel, pp 62–75Google Scholar
  36. 36.
    Hoffmann JN, Hartl WH, Deppisch R, et al (1995) Hemofiltration in human sepsis: Evidence for elimination of immunomodulatory substances. Kidney Int 48: 1563–1570Google Scholar
  37. 37.
    Bellommo R, Tipping P, Boyce N (1995) Interleukin-6 and interleukin-8 extraction during continuous venovenous hemodiafiltration in septic acute renal failure. Renal Failure 17: 457–466CrossRefGoogle Scholar
  38. 38.
    Hirasawa H, Sugai T, Ohtake Y, et al (1991) Continuous hemofiltration and hemodiafiltration in the management of multiple organ failure. In: Sieberth HG, Mann H, Stummvoll HK (eds) Continuous hemofiltration. Karger, Basel, pp 42–46Google Scholar
  39. 39.
    Staubach KH, Rau HG, Hohlbach G, et al (1987) Continuous arteriovenous hemofiltration in shock: A new strategy to lower eicosanoids. Artif Organs 11: A336 (Abst)Google Scholar
  40. 40.
    Tonnesen E, Hansen MB, Hohndrof K, et al (1993) Cytokines in plasma and ultrafiltrate during continuous arteriovenous haemofiltration. Anaesth Intensive Care 21: 752–758PubMedGoogle Scholar
  41. 41.
    Coraim F, Pauser G, Stellwag F, et al (1985) Positive modification of hemodynamics in postcardiac surgery patients by hemofiltration. Improved method for the demonstration of myocardial depressant factor in hemofiltrate. Anaesthesist 34: 236–240Google Scholar
  42. 42.
    Garzia F, Todor R, Scalea T (1991) Continuous arteriovenous hemofiltration: Counter current dialysis in acute respiratory failure. J Trauma 31: 1277–1285Google Scholar
  43. 43.
    Bellomo R, Tipping P, Boyce N (1993) Continuous veno-venous hemofiltration with dialysis removes cytokines from the circulation of septic patients. Crit Care Med 21: 522–526PubMedCrossRefGoogle Scholar
  44. 44.
    Gotloib L, Shostak A, Lev A, et al (1995) Treatment of surgical and non-surgical septic multi-organ failure with bicarbonate hemodialysis and sequential hemofiltration. Intensive Care Med 21: 104–111PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1997

Authors and Affiliations

  • P. Rogiers
  • H. Zhang
  • J.-L. Vincent

There are no affiliations available

Personalised recommendations